SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is capturing attention as the community rallies around its strategic expansion to the Stellar blockchain, viewing the integration as a major step toward real-world adoption and institutional payroll utility. Investors are actively debating the potential for further high-profile partnerships, such as with Ripple, while focusing on long-term accumulation and staking strategies despite broader market volatility.

Maul Coin

Maul Coin is currently trending as the community rallies around its organic growth and aggressive social media outreach, with supporters highlighting the developer's transparency and active involvement as key differentiators from typical meme coin projects. Investors are closely monitoring the token's price consolidation and are actively coordinating efforts to increase community awareness to push toward higher market capitalization milestones.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toast Inc. is trending as investors debate its long-term potential versus recent price volatility, with the community closely tracking whether the company can sustain its market share growth despite intense scrutiny over insider selling and competitive pressures. Discussions frequently contrast Toasts robust adoption in local restaurant ecosystems against its frustrating stock performance, leaving shareholders divided on whether to hold for a multi-year turnaround or exit amidst ongoing sector-wide software headwinds.

Select Sector SPDR Trust (The) - State Street Materials Select Sector SPDR ETF

Materials Select Sector SPDR Fund

The Materials Select Sector SPDR Fund is garnering significant attention as traders debate the sector's potential for a breakout or consolidation, with many focused on analyzing key technical indicators like the RSI and MACD for long-term entry points. Community sentiment remains mixed as participants weigh broader economic indicators, such as manufacturing and inflation data, against the impact of rotating capital flows between tech-heavy growth stocks and cyclical, value-oriented plays.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz among traders due to its ultra-low supply and small market capitalization, with many community members viewing it as a potential breakout candidate. Enthusiasts are actively highlighting the project's scarcity and historical performance as reasons to hold, while others continue to debate the timing and potential for a sharp upward move.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health is trending as the community debates the broader impact of proposed government healthcare policies, including potential Medicare Advantage payment shifts and legislative debates over Affordable Care Act subsidies. Investors remain focused on the company's long-term profitability strategies, with active community discussion centered on navigating ongoing regulatory pressures and interpreting recent executive movements.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as market attention focuses on its recent operational restructuring and Medicare Advantage star ratings, with analysts upgrading price targets amid a broader sector rotation into defensive healthcare plays. Investors are weighing these positive fundamental signals against ongoing challenges related to legal settlements, PBM scrutiny, and the potential impact of evolving federal healthcare policies.

STMicroelectronics NV is a global semiconductor company, which engages in the business of designing, developing, manufacturing, and marketing products used in a wide variety of applications for automotive, industrial, personal electronics and communications equipment, computers, and peripherals. It operates through the following segments: Automotive and Discrete Group (ADG), Analog, MEMS, and Sensors Group (AMS), Microcontrollers and Digital ICs Group (MDG), and Others. The ADG segment includes dedicated automotive integrated circuits and discrete and power transistor products. The AMS segment offers analog, smart power, MEMS sensors and actuators, and optical sensing solutions. The MDG segment focuses on general-purpose microcontrollers and microprocessors, connected security products, memories, and RF and communications products. The Others segment is involved in sales assembly services and other revenues. The company was founded in June 1987 and is headquartered in Plan-Les-Ouates, Switzerland.

ST Microelectronics - New York Shares

STMicroelectronics NV

STMicroelectronics is gaining momentum as a key supplier for AI infrastructure and robotics, recently expanding its silicon photonics platform and strengthening collaborations with industry giants like NVIDIA and AWS. The community is buzzing about the companys pivotal role in the space economy via its decade-long SpaceX partnership and its strategic expansion into high-performance data center power solutions.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is currently trending as investors monitor the company's efforts to navigate a recent regulatory setback after the FDA issued a Complete Response Letter for its melanoma treatment, RP1. The community is actively debating the likelihood of a path forward following the upcoming Type A meeting, with many long-term shareholders highlighting the therapy's durable clinical data despite the significant institutional and regulatory uncertainty surrounding its approval timeline.

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Roivant Sciences Ltd

Roivant Sciences is currently the focus of investor attention following its recent $1.2 billion divestiture of Dermavant to Organon, a move aimed at streamlining operations and reducing debt. The community is actively discussing the company's robust cash position, the strategic implications of its ongoing patent litigation involving mRNA lipid nanoparticle technology, and the potential for future acquisitions within its biotech pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

W.R. Berkley (NYSE:WRB) Price Target Cut to $66.00 by Analysts at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods lowered their target price on W.R. Berkley from $74.00 to $66.00 and set a "market perform" rating for the company in a research note on Wednesday...

W.R. Berkley (NYSE:WRB) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen cut W.R. Berkley from a "hold" rating to a "sell" rating in a report on Sunday...

Eagle Rock Investment Company LLC Has $8.34 Million Stock Holdings in W.R. Berkley Corporation $WRB

Eagle Rock Investment Company LLC increased its holdings in shares of W.R. Berkley Corporation (NYSE:WRB - Free Report) by 18.8% during the fourth quarter, according to its most recent Form 13F...

Wealth Enhancement Advisory Services LLC Increases Stake in W.R. Berkley Corporation $WRB

Wealth Enhancement Advisory Services LLC raised its stake in W.R. Berkley Corporation (NYSE:WRB - Free Report) by 17.4% in the 4th quarter, according to its most recent disclosure with the SEC. The...

SG Americas Securities LLC Grows Position in W.R. Berkley Corporation $WRB

SG Americas Securities LLC lifted its position in shares of W.R. Berkley Corporation (NYSE:WRB - Free Report) by 1,332.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 344,040 shares of the insurance provider's s...

W. R. Berkley Corporation to Announce First Quarter 2026 Earnings on April 21, 2026

W. R. Berkley Corporation (NYSE: WRB) will release its first quarter 2026 earnings after the market closes on Tuesday, April 21, 2026. A copy of the earnings release will be available on the Companys...

Arch Capital Trades Above 200-Day SMA: Time to Hold the Stock?

ACGL is poised to gain from new business opportunities, rate increases, solid premium growth and effective capital deployment.

WRB Stock Outperforms Industry: What Should Investors Do Now?

W.R. Berkley stock gains from higher premiums, lower claims frequency in certain lines of business, effective capital deployment and sufficient liquidity.

W.R. Berkley (NYSE:WRB) Lowered to "Neutral" Rating by Brean Capital

Brean Capital lowered W.R. Berkley from a "buy" rating to a "neutral" rating and set a $73.00 price objective on the stock. in a report on Wednesday...

Swiss Life Asset Management Ltd Reduces Stake in W.R. Berkley Corporation $WRB

Swiss Life Asset Management Ltd reduced its stake in shares of W.R. Berkley Corporation (NYSE:WRB - Free Report) by 13.5% in the third quarter, according to its most recent filing with the Securities...

W.R. Berkley Corp. is an insurance holding company, which engages in the property casualty insurance business. It operates through the following segments: Insurance and Reinsurance & Monoline Excess. The Insurance segment includes excess and surplus lines, admitted lines, and specialty personal lines throughout the United States, as well as insurance businesses in the United Kingdom, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia, and Australia. The Reinsurance & Monoline Excess segment is involved in the reinsurance business on a facultative and treaty basis, primarily in the United States, United Kingdom, Continental Europe, Australia, the Asia-Pacific region, and South Africa. The company was founded by William R. Berkley in 1967 and is headquartered in Greenwich, CT.

W.R. Berkley Corp.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

WRB
W.R. Berkley Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest WRB News

WRBW.R. Berkley Corp.